30 related articles for article (PubMed ID: 32199060)
1. Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease.
Takano C; Grubbs BH; Ishige M; Ogawa E; Morioka I; Hayakawa S; Miki T
Stem Cells Transl Med; 2021 Jun; 10(6):829-835. PubMed ID: 33547875
[TBL] [Abstract][Full Text] [Related]
2. Teaching NeuroImage: Optic Pathway Involvement in Maple Syrup Urine Disease.
Narra RK; Pamidi RK; Mandapalli AR
Neurology; 2022 Nov; 99(20):914-915. PubMed ID: 36240097
[No Abstract] [Full Text] [Related]
3. Maple Syrup Urine Disease.
Lai B; Zhong J
Radiology; 2024 Jan; 310(1):e232039. PubMed ID: 38193837
[No Abstract] [Full Text] [Related]
4. The Physicochemical Characterization and In Vitro Digestibility of Maple Sugar Sand and Downgraded Maple Syrups.
Decabooter G; Aspirault C; Filteau M; Fliss I
Foods; 2023 Sep; 12(19):. PubMed ID: 37835179
[TBL] [Abstract][Full Text] [Related]
5. Letter to the Editors: Concerning "Hyperleucinosis during infections in maple syrup urine disease post-liver transplantation" by Guilder et al.
Takano C; Ogawa E; Arai-Ichinoi N; Ishige M
Mol Genet Metab Rep; 2024 Mar; 38():101047. PubMed ID: 38234861
[No Abstract] [Full Text] [Related]
6. Unexpected Cola-Colored Urine in a Neonate.
Dipak NK; Shagufta N
Neoreviews; 2023 Nov; 24(11):e737-e740. PubMed ID: 37907407
[No Abstract] [Full Text] [Related]
7. [Anaesthesia in patients with maple syrup urine disease. Case report and perioperative anaesthetic management].
Haberstich P; Kindler CH; Schürch M
Anaesthesist; 2010 Oct; 59(10):914-7. PubMed ID: 20827453
[TBL] [Abstract][Full Text] [Related]
8. [MAPLE SYRUP URINE DISEASE].
TIMMERMANS J
Maandschr Kindergeneeskd; 1963 Oct; 31():337-47. PubMed ID: 14100237
[No Abstract] [Full Text] [Related]
9. [Maple Syrup Urine Disease in a newborn infant].
Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
[TBL] [Abstract][Full Text] [Related]
10. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
McMahon Y; MacDonnell RC
Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
[TBL] [Abstract][Full Text] [Related]
11. Semiquantitation of leucine, isoleucine, and valine by thin-layer chromatography in management of maple-syrup urine diseases.
Allen RJ; Frey HJ; Fleming LM; Owings CL
Clin Chem; 1972 May; 18(5):413-6. PubMed ID: 5019114
[No Abstract] [Full Text] [Related]
12. Removal of branched-chain amino acids by peritoneal dialysis, continuous arteriovenous hemofiltration, and continuous arteriovenous hemodialysis in rabbits: implications for maple syrup urine disease treatment.
Gouyon JB; Desgres J; Mousson C
Pediatr Res; 1994 Mar; 35(3):357-61. PubMed ID: 8190527
[TBL] [Abstract][Full Text] [Related]
13. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK
Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568
[TBL] [Abstract][Full Text] [Related]
14. [Peritoneal dialysis in a neonate with maple syrup urine disease. A case report].
Ramírez F; Mato I; Barboza A; Cejas Bestard N
Arch Argent Pediatr; 2020 Apr; 118(2):e178-e182. PubMed ID: 32199060
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
